1.Effect of Emotion on Blood Pressure of Patients with Primary Hypertension
Dexiang LIAO ; Chengdi YANG ; Bi ZHANG
Chinese Mental Health Journal 2002;0(12):-
Objective: To study the effect of emotion on blood pressure of patients with primary hypertension Method: 100 patients with primary hypertension completed SAS (self-rate anxiety scale) and Type A Behavior Questionnaire 62 of them had typical type A behavior, they were divided into two groups by results of SAS, 34 were SAS negative, 28 were positive The 28 patients were randomly divided into two groups, 14 received Lorsartan 50 mg daily for 30 days, the other 14 received both Paroxetine 20 mg daily and Lorsartan 50 mg daily for 30 days The 34 SAS negative patients also received Lorsartan 50 mg daily for 30 days Result: The positive rate of SAS was significant different between type A patients (28/62, 45 2%) and non-type A patients (4/38, 10 5%) In treatment of hypertension, the effective rate of Lorsartan in patients neither anxious nor type A predominant was 79 4%, that in the 14 patients with both anxiety and type A behavior was only 57 1% While in those using Lorsartan and Paroxetine, the effective rate was 78 5%, similar to that in patients neither anxious nor type A predominant Conclusion: Anxiety is much more common in hypertension patients predominant in type A behavior Treatment of anxiety is helpful to treatment of hypertension in patients both anxious and type A behavior predominant
2.Autologous bone marrow stem cell transplantation for acute myocardial infarction in 27 cases: Short-term curative effects
Dexiang LIAO ; He HUANG ; Ping LIU ; Jianping ZENG ; Zhiliu PENG ; Yuan LIU ; Lihua LIU ; Jianping SUN
Chinese Journal of Tissue Engineering Research 2007;11(37):7517-7520
BACKGROUND: Recent researches demonstrate that transplantation of bone marrow stem cells in the area of myocardial infarction can directionally differentiate into myocardial cells having normal physiological function and can promote newborn vascularization so as to repair infarction myocardium and improve injured cardiac function.OBJECTIVE: To observe short-term clinical effect of autologous bone marrow stem cell transplantation (ABMSCT) in percutaneous coronary artery on the treatment of acute myocardial infarction.DESIGN: Self-control study.SETTING: Department of Cardiology, Xiangtan Central Hospital.PARTICIPANTS: A total of 27 patients with acute myocardial infarction, including 16 males and 11 females, were selected from Department of Cardiology, Xiangtan Central Hospital from June 2004 to December 2006. Their ages coronary artery was finished after onset emergently; in addition, blood flow of infraction related vessels recovered to grade TIMI3. All patients provided the confirmed consent.METHODS: Operative procedure: All patients were performed with emergently interventional therapy of coronary artery after onset of acute myocardial infarction. One week later, percutaneous cavity tube technique was used to establish infarction related arterial pathway, and guiding filament was used to send micro-perfusion tube into stents. And then,separated bone marrow stem cell suspension was poured through central cavity of micro-tube into the distal end of infarction vessels. Operative evaluation: Dynamic electrocardiogram was evaluated for 24 hours before and after transplantation; in addition, left ventricular ejection fraction and myocardial perfusion defect scores were detected before and at 6 and 12 months after transplantation; otherwise, recovery state and complication were observed in follow up at 6 and 12 months after operation.defect scores: At 6 and 12 months after operation, left ventricular ejection fraction was higher than that before transplantation, and there was significant difference before and after transplantation (P<0.05). While, myocardial perfusion defect scores were lower than those before transplantation, and there was significant difference before and arrhythmia were not found out, cardiac arrhythmia was not increased, and cardiac arrhythmia combining with malignancy not have any complications and in-stent constriction after operation.
3.The protective of folic acid supplementation in different ways on lipopolysaccharide-induced teratogenesis in mice
Jun ZHOU ; Mei ZHAO ; Yuanhua CHEN ; Shuxian WU ; Xiaoling YU ; Jianhong LIAO ; Dexiang XU
Chinese Journal of Practical Nursing 2014;30(22):1-4
Objective To explore the protective effect of folic acid supplementation in different ways on lipopolysaccharide-induced external malformations and skeletal malformations in mice.Methods The pregnant mice were divided into six groups randomly,including saline control group,FA control group,LPS group,LPS+FAig group,LPS+FAip group,and LPS+FAdw group.All dams were medicated on gestational day 8~12,and then sacrificed on gestational day 18,for each litter,the number of live fetuses,dead fetuses,resorption fetuses and external malformations of live fetuses were all counted.All fetuses were subsequently evaluated the skeletal malformations.Results A low dose of LPS injection during the second trimester resulted in external and skeletal malformations.Exencephaly and encephalomeningocele were two of the most common external malformations,skeletal malformations consisted mainly of the incompletion of supraoccipital ossification,sternal malformation and rib malformation.FA supplementation by three ways all attenuated the external and skeletal malformations.And the best protective effect was by oral administration.The incidence of external,sternal and rib malformation was all decreased.Conclusions Three ways can prevent the mice during the second trimester from the external and skeletal malformations caused by LPS injection,and the best protective effect was by intragastric administration.
4.Clinical study of intracoronary autologous bone marrow stem cells transplantation in treating acute myocardial infarction
Ping LIU ; Jianping ZENG ; He HUANG ; Minxing WU ; Lihua LIU ; Wei CHEN ; Zhiqing WEN ; Dexiang LIAO ; Zhiliu PENG ; Jianpin SUN
Journal of Chinese Physician 2001;0(10):-
0.05).Myocardial perfusion defect scores were decreased significantly from 14.8?3.0 to 10.5?1.8(P
5.Short-term changes in the cardiac function of patients with heart failure of ischemic cardiomyopathy following autologous bone marrow stem cell transplantation: A 6-month follow-up of 21 cases
Dexiang LIAO ; Zhiliu PANG ; Ping LIU ; Jianping ZENG ; He HUANG ; Yuan LIU ; Shuzhen MO ; Liyuan WU ; Li ZHOU ; Lihua LIU
Chinese Journal of Tissue Engineering Research 2007;11(11):2187-2189
BACKGROUND:Animal experiments have demonstrated that transplanted bone marrow stem cells (BMSCs)in the myocardial infarction region can directionally differentiate into myocardial cells with normal physiological function and promote neovascularization. Clinical studies have also showed that the cardiac function can be improved in myocardial infarction and cardiomyopathy patients after stem cell transplantation.OBJECTIVE: To observe the effect of autologous BMSCs transplantation on short-term cardiac function of patients with heart failure of ischemic cardiomyopathy.DESIGN: Self-control study.SETTING: Department of Cardiology, Xiangtan Central Hospital.PARTICIPANTS: Twenty-one patients with ischemic cardiomyopathy, including 13 males and 8 females, aged (64±6)years,who received treatment in the Department of Cardiology,Xiangtan Central Hospital of Hunan Province from March 2004 to January 2006 were retrieved. Inclusive criteria: with previous myocardial infarction at least once, B-mode ultrasonic cardiac examination showed that cardiac chamber was expanded, obvious cardiac inadequacy or stenocardia existed before stent implantation and hospitalized repeatedly, underwent percutaneous coronary artery intervention for restoring blood flow of infarcted vessel to TIMI3 degree over 3 months,but cardiac inadequacy existed to different degrees.Coronary arteriongraphy showed that no stenosis was found in the stent implanted in the coronary artery.Informed consents were obtained from all the patients.METHODS:After admission, all the patients received BMSCs transplantation based on routine drug treatment.Infarction-related arterial passage was established by percutaneous transluminal catheter technique and occluded by balloon.Isolated bone marrow stem cell suspension was injected into infarction-related arterial passage through the central cavity of catheter. ① Left ventricular ejection fractions (LVEF) and left ventricular end-diastolic diameter(LVDd)were measured before and 6 months after transplantation.② 24-hour dynamic electrocardiogram evaluation was conducted before and 6 months after transplantation under the precondition of not taking antiarrhythmic drugs. ③Clinical cardiac functional grading was conducted before and 6 months after transplantation by NYHA grading method: Grade Ⅰto Ⅳ: the higher grade, the severer symptom. ④ Adverse events and side effects were observed after operation.MAIN OUTCOME MEASURES:① LVEF and LVDd were measured before and 6 months after transplantation. ②24-hour dynamic electrocardiogram evaluation results. ③ Clinical cardiac functional grading evaluation results. ④ Post-operative adverse events and side effects.RESULTS:All the involved 21 patients participated in the result analysis.①The LVEF of patients 6 months after transplantation of BMSCs was more than that before transplantation [(54.4±6.2)%, (44.6±6.4)%,t = -5.946, P< 0.01], and LVDd of patients 6 months after transplantation was smaller than that before transplantation [(54.6±4.2), (60.2±4.4) mm,t = 5.306, P < 0.01]. ② No new arrhythmic types appeared, and case of malignant serious cardiac arrhythmias were not increased. ③ Six months after transplantation of BMSCs, there were totally 9 patients with cardiac function of grade Ⅲ and Ⅳ, while there were 18 patients before transplantation. ④ The whole transplantation was safe.No patients were found to undergo re-examination of coronary arteriongraphy, which showed stent necrosis, due to chest pain, and no dead cases were either found.CONCLUSION:It is feasible to treat ischemic cardiomyopathy by percutaneous coronary transplantation of BMSCs,which can boost LVEF and improve cardiac function after transplantation.
6.Relationship between dietary inflammatory index during the second trimester of pregnancy and preterm ;birth
Xiaoling YU ; Mei ZHAO ; Hongju WANG ; Chang SU ; Li YUAN ; Manman YUAN ; Xinqiong ZHANG ; Yan HU ; Huan YU ; Jianhong LIAO ; Yuanhua CHEN ; Dexiang XU
Chinese Journal of Clinical Nutrition 2016;24(2):91-95
Objective To assess the diet quality of pregnant women during the second trimester using the dietary inflammatory index ( DII) and to explore the correlation between the DII in second trimester of preg-nancy and preterm delivery.Methods A total of 253 women with singleton pregnancy in 16-20 gestational weeks who had received routine prenatal care between August 2014 and April 2015 at the First Affiliated Hospi-tal of Anhui Medical University were enrolled with cluster random sampling.The included women were asked to recall daily dietary intake in the 3 days prior to the survey.All dietary data were analyzed for energy and nutri-ents intake with a nutritional analysis software, followed by calculation of DII according to previous reports. Based on quartiles of the DII scores, the participants were divided into three groups, namely the anti-inflam-matory group (DII<-5.10), intermediate group (DII -5.10--2.55), and the pro-inflammatory group (DII>-2.55).The participants were followed up until delivery and the pregnancy outcomes were recorded. The relationship between the DII in second trimester of pregnancy and preterm delivery were analyzed. Results DII scores of the 253 pregnant women during the second trimester of pregnancy ranged from -7.913 to 3.872.The risks of preterm birth in the anti-inflammatory diet group, the intermediate group, and the pro-inflammatory diet group were 0, 1.6%, and 6.3%, respectively, with statistically significant differences among the groups (P=0.034).The higher DII scores (pro-inflammatory) were associated with higher inci-dence of preterm birth ( P<0.05 ) .Conclusion DII may be used to assess diet quality of pregnant women during the second trimester and to predict the risk of preterm birth.